Jardine AG - Search Results

1

The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response.

Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A. Lisboa LF, et al. Among authors: jardine ag. Transplantation. 2011 Jan 27;91(2):231-6. doi: 10.1097/TP.0b013e3181ff8719. Transplantation. 2011. PMID: 21048530 Clinical Trial.

2

Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation.

Asberg A, Holdaas H, Jardine AG, Edvardsen C, Hartmann A. Asberg A, et al. Among authors: jardine ag. Clin Transplant. 2003 Aug;17(4):385-90. doi: 10.1034/j.1399-0012.2003.00063.x. Clin Transplant. 2003. PMID: 12868997 Clinical Trial.

3

Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients.

Asberg A, Humar A, Rollag H, Jardine AG, Mouas H, Pescovitz MD, Sgarabotto D, Tuncer M, Noronha IL, Hartmann A; VICTOR Study Group. Asberg A, et al. Among authors: jardine ag. Am J Transplant. 2007 Sep;7(9):2106-13. doi: 10.1111/j.1600-6143.2007.01910.x. Epub 2007 Jul 19. Am J Transplant. 2007. PMID: 17640310 Free article. Clinical Trial.

4

Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients.

Asberg A, Humar A, Jardine AG, Rollag H, Pescovitz MD, Mouas H, Bignamini A, Töz H, Dittmer I, Montejo M, Hartmann A; VICTOR Study Group. Asberg A, et al. Among authors: jardine ag. Am J Transplant. 2009 May;9(5):1205-13. doi: 10.1111/j.1600-6143.2009.02617.x. Am J Transplant. 2009. PMID: 19422345 Free article. Clinical Trial.

5

Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.

Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A. Boivin G, et al. Among authors: jardine ag. Antivir Ther. 2009;14(5):697-704. Antivir Ther. 2009. PMID: 19704173 Clinical Trial.

6

Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.

Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A. Manuel O, et al. Among authors: jardine ag. Clin Infect Dis. 2009 Oct 15;49(8):1160-6. doi: 10.1086/605633. Clin Infect Dis. 2009. PMID: 19751151 Clinical Trial.

7

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients.

Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P. Humar A, et al. Among authors: jardine ag. Am J Transplant. 2010 May;10(5):1228-37. doi: 10.1111/j.1600-6143.2010.03074.x. Epub 2010 Mar 26. Am J Transplant. 2010. PMID: 20353469 Free article. Clinical Trial.

8

Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients.

Asberg A, Jardine AG, Bignamini AA, Rollag H, Pescovitz MD, Gahlemann CC, Humar A, Hartmann A; VICTOR Study Group. Asberg A, et al. Among authors: jardine ag. Am J Transplant. 2010 Aug;10(8):1881-8. doi: 10.1111/j.1600-6143.2010.03114.x. Epub 2010 May 10. Am J Transplant. 2010. PMID: 20486914 Free article. Clinical Trial.

9

Prolonged prophylaxis with valganciclovir is cost effective in reducing posttransplant cytomegalovirus disease within the United States.

Blumberg EA, Hauser IA, Stanisic S, Mueller E, Berenson K, Gahlemann CG, Humar A, Jardine AG. Blumberg EA, et al. Among authors: jardine ag. Transplantation. 2010 Dec 27;90(12):1420-6. doi: 10.1097/TP.0b013e3181ff500d. Transplantation. 2010. PMID: 21063245

10

Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study.

Humar A, Limaye AP, Blumberg EA, Hauser IA, Vincenti F, Jardine AG, Abramowicz D, Ives JA, Farhan M, Peeters P. Humar A, et al. Among authors: jardine ag. Transplantation. 2010 Dec 27;90(12):1427-31. doi: 10.1097/tp.0b013e3181ff1493. Transplantation. 2010. PMID: 21197713 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page